Showing 801-810 of 9075 results for "".
Various Skin Cancer Therapies Covered at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/various-skin-cancer-therapies-covered-at-maui-derm/32915/With a theme of understanding the various options available for treatment of skin cancers and selecting the correct ones for each case, George Martin, MD, Ted Rosen, MD, and Emily Ruiz, MD, MPH, presented “Cutaneous Oncology Update 2025” at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.Leading Dermatologists Summarize Maui Derm Presentations
https://practicaldermatology.com/series/dermwire-tv/leading-dermatologists-summarize-maui-derm-presentations/32839/In this week's DermwireTV, top thought leaders provide a summary of their presentations at Maui Derm; a new analysis examines a link between hidradenitis suppurativa genetics and coronary artery disease risk; and the president of Castle Biosciences joins us for this week's C-Suite Chats fJournal Club: Dupilumab and Risk of Malignancy
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-dupilumab-and-risk-of-malignancy/32398/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Matthew Zirwas, MD, about the Journal of Allergy and Clinical Immunology: In Practice article "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national databaseImproving the After-Sun Treatment Market
https://practicaldermatology.com/series/c-suite-chats/improving-after-sun-treatment-market/29805/Ed Esquenazi, PhD, Founder and CEO of health and performance company, Terns, discusses the after-sun treatment market and two new products designed to combat inflammation and aging after exposure to the sun.Growth Potential of the Aesthetic Market
https://practicaldermatology.com/series/c-suite-chats/growth-potential-of-the-aesthetic-market/29746/Merz Aesthetics President, North America, Patrick Urban discusses why he expects demand for aesthetic treatments to continue increasing and how to capitalize on it.SDPA: Dr. Matthew Zirwas Shares Passion for Treating Atopic Dermatitis
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-dr-matthew-zirwas-shares-passion-for-treating-atopic-dermatitis/29509/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Matthew Zirwas, MD. He provides a passionate overview of his lecture on atopic dermatitis, itch, and contact dermatitis.SDPA: Andrew Mastro on Advancing Career By Building Yearly Goals
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-andrew-mastro-on-advancing-career-by-building-yearly-goals/29512/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Andrew Mastro, PA-C. Each year, Mastro leaves SDPA with a yearly goal in mind. He breaks down how SDPA contributes to the goal and what he does to achieve it.ASDS: Dr. Green on the Annual Meeting
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-green-annual-meeting/29169/Lawrence Green, MD, FAAD, talks about the education and networking that make the American Society for Dermatologic Surgery Annual Meeting special.PASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/pasi-hd-new-method-for-measuring-severity-in-mild-to-moderate-plaque-psoriasis/20185/Robert Higham, MPAS, PA-C, Executive Director of Clinical Development of Arcutis Biotherapeutics, discusses PASI-HD, a new measure designed to assess severity and therapeutic response in patients with mild and moderate psoriasis. PASI High Discrimination (PASI-HD) was developed to better understandMeaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.